InvestorsHub Logo
Followers 13
Posts 1106
Boards Moderated 0
Alias Born 02/01/2023

Re: None

Saturday, 05/27/2023 3:27:53 PM

Saturday, May 27, 2023 3:27:53 PM

Post# of 462249
A question about Precision Medicine trials.

Missling or somebody referred to Biogen or Lilly screening 8,000 patients to get their quota for an Alzheimer's drug trial of <2000 patients, filtering for specific ratios of tau-subtypes (IIRC) and similar requirements. I can't find the reference (though I'd appreciate it if someone replied with it).

Did that screening make the trial a Precision Medicine trial? If not, why not? If it's not regarded as PM, isn't that stacking the deck?

Does that kind of screening limit for whom the drug, if approved, is labeled?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News